Anaplastic Astrocytoma
📧 Sign up to get email alerts when something new happens for Anaplastic Astrocytoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-02-10Clinical Trial Update: HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma [Phase 2]
A Phase 2 trial evaluating HSV G207 with a single radiation dose for children with recurrent high-grade glioma has been withdrawn from Clini…
-
CLINICAL_TRIALS withdrawal · 2020-03-24Clinical Trial Update: Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma [Phase 2, Phase 3]
Clinical trial evaluating Toca 511/Toca FC added to standard therapy for newly diagnosed glioblastoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-07-20Clinical Trial Update: Fluorescein vs. iMRI in Resection of Malignant High Grade Glioma [NA]
The clinical trial NCT02540135 evaluating fluorescein-guided resection with intraoperative MRI for malignant high-grade gliomas has been wit…
-
CLINICAL_TRIALS withdrawal · 2015-05-22Clinical Trial Update: Valproic Acid in Childhood Progressive Brain Tumors [Phase 1]
The trial withdrawal notice states that the Phase 1 study of valproic acid for childhood progressive brain tumors has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-05-12Clinical Trial Update: Re-irradiation of High Grade Gliomas: a Quality of Life Study
A clinical trial studying re-irradiation for high-grade gliomas with a quality-of-life focus has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2014-06-02Clinical Trial Update: Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas [Phase 1]
Phase 1 trial evaluating genetically modified stem cells with Irinotecan hydrochloride for recurrent high-grade gliomas has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-11-21Clinical Trial Update: Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma [Phase 1]
A Phase I trial of dasatinib in combination with protracted temozolomide for recurrent malignant glioma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-02-22Clinical Trial Update: Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas [Phase 3]
A Phase 3 trial assessing procarbazine with isotretinoin for recurrent primary malignant gliomas has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2010-01-12Clinical Trial Update: Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors [Phase 2]
Phase 2 trial of photodynamic therapy for malignant intracranial tumors has been withdrawn from ClinicalTrials.gov.